Requests that the FDA determine whether Tovalt ODT (Zolpidem Tartrate), 5mg and 10mg Orally Disintegrating Tablets, New Drug Application 021412 had been voluntarily withdrawn from sale for safety or efficacy reasons.
🏛 Food and Drug Administration (FDA)FDA-2026-P-1636
Documents
3
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Feb 13, 2026No comment period